Search clinical trials for: Adhansia XR

Total 584 results

Purdue Pharma LP

Terminated

Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children

Attention Deficit/Hyperactivity Disorder

United States
VA Office of Research and Development
VA New York Harbor Healthcare System; VA Boston Healthcare System; Portland VA... and other collaborators

Recruiting

Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

Epilepsy

United States
Eisai Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years

Obesity

United States
Institute for Bioengineering of Catalonia
Hospital Universitari Joan XXIII de Tarragona.; Universitat Pompeu Fabra

Completed

Remote Neurobased Approach to Aphasia Therapy (RNAAT)

Aphasia | Aphasia, Broca | Aphasia, Wernicke | Aphasia, Fluent | Aphasia, Nonfluent

Spain
Purdue Pharma, Canada

Completed

Real World Evidence of the Efficacy and Safety of FOQUEST (reFOQus)

Attention Deficit-Hyperactivity Disorder

Canada
Sunnaas Rehabilitation Hospital
South-Eastern Norway Regional Health Authority

Completed

Aphasia Telerehabilitation (AT)

Stroke | Aphasia

Norway
Purdue Pharma LP

Terminated

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) (RE-DAX)

Attention-Deficit/Hyperactivity Disorder

United States
Universitat Pompeu Fabra
Hospital Universitari Joan XXIII de Tarragona.

Completed

Virtual Reality Based Sensorimotor Speech Therapy

Broca's Aphasia

Spain
UCB Pharma

Completed

Long Term Follow-up Study With Keppra XR (Levetiracetam XR) for Partial Seizures

Epilepsy

United States, Poland, Mexico, Russian Federation
Coopervision, Inc.

Completed

Multicenter Dispensing Study of Biofinity Lenses in Extended Range

Myopia | Hyperopia

United States, Canada
Supernus Pharmaceuticals, Inc.

Completed

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Epilepsy

United States
FUSMobile Inc.

Active, not recruiting

Safety and Initial Feasibility of Using the Neurolyser XR Device for the Treatment of Axial Chronic Low Back Pain

Facet Syndrome of Lumbar Spine

Canada
Envisia Therapeutics

Completed

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Glaucoma and Ocular Hypertension

United States
Meir Medical Center

Unknown

Clinical and Radiologic Follow up of Subchondral Fractures of the Glenoid

Subchondral Fractures of the Glenoid
University Ghent
University Hospital, Ghent

Terminated

tDCS and Aphasia Therapy in the Chronic Phase After Stroke

Aphasia Following Cerebral Infarction | Aphasia Following Nontraumatic Intracerebral Hemorrhage

Belgium
Upsher-Smith Laboratories

Recruiting

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

Migraine Disorders

United States
Swiss Federal Institute of Sport Magglingen

Unknown

Validation Sonic Bone's Ultrasound System for Bone Age Assessment (BAUS)

Bone Age Assessment

Switzerland
Mayo Clinic
GlaxoSmithKline

Completed

Assessment of Coronary Plaque Composition Using Optical Coherence Tomography

Endothelial Dysfunction | Coronary Atherosclerosis | Coronary Small Vessel Disease

United States
UCB BIOSCIENCES, Inc.

Completed

Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy

Epilepsy

United States
Boston University Charles River Campus
Temple University; Adler Aphasia Center

Recruiting

Conversation Group Treatment for Aphasia: Does it Work?

Aphasia, Acquired

United States
Boston University Charles River Campus

Completed

Intensive Interdisciplinary Treatment Program for Individuals With Stroke-Induced Aphasia

Aphasia
Dexa Medica Group

Completed

Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome (PCOS)

Indonesia
Smith & Nephew, Inc.
Nor Consult, LLC

Completed

Safety and Performance of Journey II XR Total Knee System (JIIXR)

Journey II XR Total Knee System

United States
University Hospital, Ghent

Completed

Tablet-based Aphasia Therapy in the Acute Phase After Stroke

Aphasia | Stroke, Acute

Belgium
Alexandria University

Completed

Post Stroke Aphasia Rehabilitation Using Computer-based Arabic Software Program: A Randomized Control Trial (aphasia)

Aphasia Rehabilitation

Egypt
University Hospitals Cleveland Medical Center
National Alliance for Research on Schizophrenia and Depression; AstraZeneca

Completed

Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)

Anxiety Disorders | Anxiety | Bipolar Disorder | Substance Use Disorders

United States
AstraZeneca

Completed

A Study to Assess the Bioequivalence of Fixed Dose Combination of Dapagliflozin/Metformin XR Relative to Co-administration of the Individual Components in Healthy Chinese Subjects.

Healthy Volunteer

China
Eckehart SCHÖLL
Basel Academy for Quality and Research in Medicine; Prof. Dr. Werner Vach... and other collaborators

Recruiting

Accuracy of Sonography in Elbow Trauma (SONOELB)

Elbow Fracture | Elbow Sprain | Distal Humerus Fracture | Radial Head Fracture | Coronoid Process Fracture

Switzerland
Incyte Corporation

Active, not recruiting

A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.

Healthy Participants

United States
Takeda

Completed

Phase 1, Febuxostat XR Relative Bioavailability Study

Healthy Volunteers

United States
University Ghent
University Hospital, Ghent

Terminated

tDCS and Aphasia Therapy in the Acute Phase After Stroke

Aphasia Following Cerebral Infarction

Belgium
University of Alberta
University of Toronto; Technische Universität Berlin; AIT Austrian Institute... and other collaborators

Active, not recruiting

Voice Adaptive Tablet-Based Naming Treatment for Adults With Aphasia (VoiceAdapt)

Aphasia

Canada
AstraZeneca

Completed

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Schizophrenia

Malaysia
Ankara City Hospital Bilkent

Completed

The Inter-rater Reliability of the Turkish Version of Aphasia Rapid Test for Stroke

Aphasia

Turkey
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Recruiting

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Bristol-Myers Squibb

Completed

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

South Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
Samsung Medical Center

Completed

Dual Site-dual Channel Non-invasive Brain Stimulation for Language and Cognitive Function in Stroke Patients

Stroke | Cognitive Impairment | Aphasia

Korea, Republic of
Columbia University
Pitkin Foundation

Terminated

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

Stroke

United States
UCB Pharma

Completed

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Epilepsy

Brazil, Finland, India, Mexico, Russian Federation, South Africa, Ukraine
Handok Inc.

Completed

A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs

Healthy Volunteers

Korea, Republic of
Karolinska Institutet

Completed

MIRAA - Implementation of Intensive Rehabilitation of Aphasia and/or Apraxia of Speech in Swedish Healthcare (MIRAA)

Stroke | Aphasia | Apraxia of Speech

Sweden
St. Olavs Hospital
Smith & Nephew, Inc.

Not yet recruiting

Robotic Assisted Knee Arthroplasty - Retain the Anterior Cruciate Ligament or Not

Arthroplasty | Arthritis Knee | Gait Analysis

Norway
Boehringer Ingelheim
Eli Lilly and Company

Completed

Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single Tablets

Healthy

United States
California State University, East Bay

Completed

Effect of Participation in Virtual Exercise Sessions in Persons With Aphasia

Aphasia, Acquired

United States
Old Dominion University
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

Treatment for Word Retrieval Impairments in Aphasia

Stroke

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA)

Recruiting

Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CURB-2)

Cocaine Use Disorder

United States
Eisai Co., Ltd.

Completed

A Study of APD356 (Lorcaserin) in Healthy Japanese Adult Subjects

Healthy Subjects

Japan
Merck KGaA, Darmstadt, Germany

Completed

Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes (CONSENT)

Diabetes Mellitus, Type 2

Germany
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Fasting

United States
Methodist Healthcare

Completed

Envarsus XL Immunosuppression Following Liver Transplantation

Recipients of Liver Transplant

United States

Search clinical trials for: Adhansia XR

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations